Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure
Paul G. Richardson(Harvard University), Robert J. Soiffer(Dana-Farber Cancer Institute), Marcie Riches(Medical College of Wisconsin), Leslie Lehmann(Harvard University), Joseph M. Massaro(Boston University), Joel A. Brochstein(Cohen Children's Medical Center), Alfred P. Gillio(University Medical Center), Ralph B. D’Agostino(Wake Forest University), Eneida R. Nemecek(Oregon Health & Science University), Sally Arai(Stanford Medicine), Richard E. Champlin(The University of Texas MD Anderson Cancer Center), Joseph H. Antin(Dana-Farber Cancer Institute), Eva C. Guinan(Dana-Farber Cancer Institute), Shin Mineishi(University of Alabama at Birmingham), Sergio Giralt(Memorial Sloan Kettering Cancer Center), Tulio E. Rodriguez(Loyola University Medical Center), Massimo Iacobelli(Figli Adottivi e Genitori Naturali), Gideon Steinbach(University of Washington), Angela R. Smith(University of Minnesota Children's Hospital), Stephan A. Grupp(Children's Hospital of Philadelphia), Nancy A. Kernan(Memorial Sloan Kettering Cancer Center), Maja Miloslavsky(Janssen (United States)), Bijan Nejadnik(Janssen (United States)), Alison L. Hannah(CytomX Therapeutics (United States)), John Doyle(Analysis Group (United States)), Paul L. Martin(Duke University), Reggie Duerst(Lurie Children's Hospital), Diane Warren(Dana-Farber Cancer Institute), Robin Hume(Jazz Pharmaceuticals (United States)), Rajinder Bajwa(Nationwide Children's Hospital), Amrita Krishnan(City of Hope), Amanda Termuhlen
Cited by 333
Related Papers
Prediction of Coronary Heart Disease Using Risk Factor Categories
|Circulation|1998|9.6k
General Cardiovascular Risk Profile for Use in Primary Care
|Circulation|2008|7.4k
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Impact of Atrial Fibrillation on the Risk of Death
|Circulation|1998|4.6k